A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer– everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy

To investigate clinical outcomes of percutaneous coronary intervention using a sirolimus-eluting stent with bioresorbable polymer, Ultimaster (BP-SES) compared with a permanent polymer everolimus-eluting stent, Xience (PP-EES) in patients with high risk (ST-segment elevation and non ST-segment elevation myocardial infarction) acute coronary syndromes (ACS) enrolled in the CENTURY II trial.

Source: Cardiovascular Revascularization Medicine - April 14, 2016 Category: Cardiology Authors: Victor A. Jiménez, Andrés Iñiguez, José A. Baz, Mariano Valdés, Alberto Ortiz, André Vuilliomenet, Vicente Mainar, Dariusz Dudek, Shmuel Banai, David Tüller, Jean-Louis Bonnet, Antonio De Miguel, Guillermo Bastos, William Wijns, Shigeru Saito Source Type: research